Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 12 | 303 | 25 | 43 | 234 |
| Cost of Goods | 11 | 9 | 3 | 3 | 18 |
| Gross Profit | 1 | 295 | 22 | 40 | 215 |
| Operating Expenses | 3,721 | 3,609 | 4,833 | 2,733 | 2,521 |
| Operating Income | -3,709 | -3,305 | -4,808 | -2,690 | -2,287 |
| Interest Expense | 0 | -74 | -100 | -278 | 0 |
| Other Income | 671 | 575 | -632 | 777 | 1,196 |
| Pre-tax Income | -3,038 | -2,656 | -5,340 | -1,636 | -1,091 |
| Net Income Continuous | -3,038 | -2,656 | -5,340 | -1,636 | -1,091 |
| Net Income | $-3,038 | $-2,656 | $-5,340 | $-1,636 | $-1,091 |
| EPS Basic Total Ops | -0.33 | -0.30 | -0.64 | -0.20 | -0.13 |
| EPS Basic Continuous Ops | -0.33 | -0.30 | -0.64 | -0.19 | -0.13 |
| EPS Diluted Total Ops | -0.33 | -0.30 | -0.64 | -0.20 | -0.13 |
| EPS Diluted Continuous Ops | -0.33 | -0.30 | -0.64 | -0.19 | -0.13 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.30 | -0.56 | -0.20 | -0.13 |
| EBITDA(a) | $-3,656 | $-3,253 | $-4,756 | $-2,640 | $-2,239 |